HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.300
-0.060 (-2.54%)
At close: Apr 2, 2026, 4:00 PM EDT
2.370
+0.070 (3.04%)
After-hours: Apr 2, 2026, 7:03 PM EDT
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$578
Profits / Employee
-$565,687
Market Cap
7.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Apr 30, 2025 | 15 | 0 | - |
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Vivos Therapeutics | 262 |
| Lifeward | 81 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 37 |
| Sintx Technologies | 32 |
HSCS News
- 9 days ago - HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - GlobeNewsWire
- 9 days ago - HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings - GlobeNewsWire
- 17 days ago - HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - GlobeNewsWire
- 2 months ago - Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - GlobeNewsWire
- 3 months ago - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - GlobeNewsWire
- 4 months ago - HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - GlobeNewsWire